Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1204320120280020109
Laboratory Animal Research
2012 Volume.28 No. 2 p.109 ~ p.114
Altered expression of ¥ã-secretase components in animal model of major depressive disorder induced by reserpine administration
Lee Hye-Ryun

Hwang In-Sik
Kim Ji-Eun
Choi Sun-Il
Lee Young-Ju
Goo Jun-Seo
Lee Eon-Pil
Choi Hae-Wook
Kim Hong-Sung
Lee Jae-Ho
Jung Young-Jin
Hwang Dae-Youn
Abstract
Altered expression of neurotrophic factors as well as neuroinflammation is commonly associated with Major depressive disorder (MDD) and Alzheimer's disease (AD). To investigate whether or not reserpine-induced MDD affects the expression of AD-related proteins, the expression of ¥ã-secretase components and substrate were measured in brains of ICR mice following reserpine treatment for 15 days. In active avoidance test, total response time and peak slightly increased in the 2 mg/kg reserpine (RSP2)-treated group compared to vehicle-treated group (P<0.05). Expression and phosphorylation of MKP-1, which is a key factor in MDD pathology, were both higher in the RSP2-treated group than the vehicle- and 1 mg/kg reserpine (RSP1)-treated groups (P<0.02). Furthermore, full-length expression of amyloid precursor protein (APP) was enhanced in the RSP1 and RSP2-treated groups compared to the vehicle-treated group, whereas expression of ¥ã-secretase components decreased (P<0.03). Among the three components of the ¥ã-secretase complex, nicastrin protein underwent the largest decrease in expression, as detected by Western blotting (P<0.03). Therefore, the data presented here provide additional evidence about the pathological correlation between MDD and AD.
KEYWORD
Major depressive disorder, Alzheimer's disease, reserpine, ¥ã-secretase, APP
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed